Dengue tetravalent vaccine, live.
The US FDA has approved Dengvaxia only for children aged 9-16 years. It may increase the likelihood of contracting serious infection in other age groups.
Nursing Central is an award-winning, complete mobile solution for nurses and students. Look up information on diseases, tests, and procedures; then consult the database with 5,000+ drugs or refer to 65,000+ dictionary terms. Complete Product Information.